Skip to main content

Table 1 Characteristics of Chinese PD patients with and without ICRDs

From: Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients

  

Mean ± SD

  

Characteristic

All(n = 142)

Without ICRDs(n = 98)

ICRDs Positive(n = 44)

P value

Male,%

51.4

55.1

43.2

0.208

Age at study,y

68.39 ± 8.14

69.67 ± 8.16

65.55 ± 7.43

0.005

Age of PD onset,%

   

<0.001

≤55y

24.6

15.3

45.5

 

56-60y

16.2

16.3

15.9

 

>60y

59.2

68.4

38.6

 

PD duration,y

6.00 ± 5.56

5.22 ± 5.23

7.76 ± 5.90

0.010

Current Smoking,%

21.1

16.3

31.8

0.037

Current Alcoholism,%

16.2

18.4

11.4

0.336

L-dopa medication,%

68.3

64.3

77.3

0.172

DA medication,%

49.3

40.8

68.2

0.003

Total LEDD,mg

389.40 ± 373.72

329.82 ± 340.65

522.06 ± 412.46

0.006

L-dopa LEDD,%

   

0.061

≤250 mg

43.7

48.0

34.1

 

250-500 mg

32.4

33.7

29.5

 

>500 mg

23.9

18.4

36.4

 

DA LEDD,%

   

<0.001

≤50 mg

63.4

71.4

45.5

 

51-100 mg

25.4

24.5

27.3

 

>100 mg

11.3

4.1

27.3

 

L-dopa treatment duration,y

3.89 ± 5.25

3.42 ± 5.21

4.98 ± 5.23

0.042

DA treatment duration,y

1.93 ± 3.00

1.44 ± 2.32

3.03 ± 3.93

0.020

H&Y stage

2.25 ± 0.84

2.21 ± 0.77

2.32 ± 0.99

0.727

UPDRS Total

33.23 ± 19.06

32.17 ± 19.32

35.59 ± 18.46

0.208

UPDRS I

3.17 ± 1.77

3.13 ± 1.79

3.25 ± 1.77

0.710

UPDRS II

9.61 ± 6.22

9.34 ± 5.97

10.23 ± 6.79

0.666

UPDRS III

19.32 ± 12.42

18.93 ± 12.82

20.18 ± 11.56

0.390

UPDRS IV

0.99 ± 2.27

0.57 ± 1.39

1.93 ± 3.36

0.020

UPDRS 32 + 33

0.29 ± 1.00

0.11 ± 0.66

0.68 ± 1.46

0.001

Freezing of gait

4.10 ± 7.41

2.96 ± 6.40

6.64 ± 8.85

0.010

MMSE score, %

   

0.049

10–20

12.0

8.2

20.5

 

21–26

27.5

25.5

31.8

 

≥27

60.6

66.3

47.7

 

NMS score

27.51 ± 22.07

27.29 ± 23.67

28.02 ± 18.24

0.318

HAMA score

6.49 ± 5.30

5.83 ± 5.15

7.95 ± 5.40

0.020

HAMD score

7.63 ± 7.50

7.53 ± 7.58

7.84 ± 7.39

0.657

RBDSQ-HK score

18.15 ± 15.78

17.36 ± 16.20

19.93 ± 14.83

0.192

PDQ-39 score

20.28 ± 18.28

19.95 ± 18.19

21.02 ± 18.66

0.752

  1. Abbreviations: LEDD levodopa equivalent daily dose, UPDRS Unified Parkinson’s disease Rating Scale, MMSE Minimum Mental State Examination, NMS non-motor symptom, HAMA Hamilton Anxiety Scale, HAMD Hamilton Depression Scale, RBDSQ-HK REM Sleep Behavior Disorder Questionnaire Hong Kong, PDQ-39 Parkinson’s Disease Questionaire-39